Biotechnology Archives - Page 29 of 32

Biotechnology

Versartis Shares Plunged a Whopping 82% Today

Versartis Inc. (NASDAQ:$VSAR) shares plunged a whopping 82% late Thursday. Why? It all started after the California-based biopharmaceutical company announced that its drug Somavaratan failed to meet its endpoint in a phase 3 trial. The ... [Read]

Biotechnology

Intercept Pharmaceuticals Plunged Today, Here’s Why

Sep 21 Caroline Harris

On Thursday, September 21, as of 3:26 p.m. EDT, Intercept Pharmaceuticals (NASDAQ:$ICPT) plunged 21%. What happened? Well, the fall began after the FDA released a safety announcement warning the public that when Intercept’s liver disease ... [Read]

Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering

Sep 21 Dylan Bernhardt

Iovance Biotherapeutics, Inc (NASDAQ:$IOVA) has announced pricing for their $50 million common stock offering. The company will offer 7,692,308 shares of its common stock at the price of $6.50 per share. Gross profits from this ... [Read]

Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating

Sep 21 Dylan Bernhardt

In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]

VBI Vaccines’ Rating Upgraded by Zacks Investment Research

Sep 20 Dylan Bernhardt

VBI Vaccines Inc (NASDAQ:$VBIV) saw its stock rating with Zacks Investment Research rise from ‘Sell’ to ‘Hold’ in a research note from Tuesday. VBIV is a biopharmaceuticals company that develops new technology focused on expanding ... [Read]

This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics

Sep 19 Dylan Bernhardt

Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) is a huge mover this week as shares have increased 5.10%, or $0.4 during the last trading session. In total, about 568,977 shares have been traded, 39.85% up from the average. ... [Read]

Biotechnology

Nabriva Therapeutics Stock Increased Today, Here’s Why

Sep 19 Caroline Harris

If you’re looking to get into biotech investing, you might want to think about adding Nabriva Therapeutics (NASDAQ:$NBRV) to your investment portfolio. For the second day in a row, the company is witnessing double-digit gains. ... [Read]

The Road Ahead for Spectrum Pharmaceuticals, Inc.

Sep 19 Dylan Bernhardt

Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) experienced a disappointing day during trading on Monday, September 18. The stock dipped -0.69% to a closing price of $10.10. The stock normally trades 894.52 million shares a day, but on ... [Read]

Biotechnology

The Recipe Behind Abeona Therapeutics’ 6 Months Dominance

Sep 18 Jen Jiang

As of 2:50 EDT, Abeona Therapeutics (NASDAQ:$ABEO) have surged a whopping 18%. This came after an analyst from RBC Capital granted the biotech company an outperform rating and assigned a $23 price target, more than ... [Read]

Here is What You Need to Measure VBI Vaccines Inc.’s Momentum

Sep 15 Jen Jiang

As of morning trading, VBI Vaccines Inc. (NASDAQ:$VBIV) shares are revealing a strong upward momentum, with the Aroon indicator reading above 70. Many investors are intrigued. Let’s look at the different metrics of measurement used ... [Read]